Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction
Not Applicable
Not yet recruiting
- Conditions
- HFrEF - Heart Failure With Reduced Ejection Fraction
- Registration Number
- NCT06166823
- Lead Sponsor
- Instituto Cardiovascular de Buenos Aires
- Brief Summary
OPTIMAL-HF is a pragmatic, cluster randomized, single-blind intervention trial that will be conducted at an outpatient clinic in Argentina. The trial will assess the effectiveness of an individualized-based alert system compared to usual care in improving GDMT optimization at 90 days in patients with HFrEF.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
- Eligible patients will include those with an EF ≤ 40% on their most recent echocardiogram, age > 18, and an outpatient cardiology encounter during the study period.
- Age 18 or over
Exclusion Criteria
- under optimal medical treatment
- palliative care, or undergoing hemodialysis will be excluded
Cardiologist
Inclusion criteria:
Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study.
Exclusion criteria Cardiologists belonging to the heart failure service
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The primary efficacy endpoint will be the GDMT optimize score in HfrEF patients 90 days after randomization. 90 days
- Secondary Outcome Measures
Name Time Method